Experimental Ebola Treatments Bypassing Usual Regulatory Hurdles

Experimental Ebola treatments are moving with lightning speed through a regulatory process that, for most drugs, can take years. The urgency of the lethal epidemic in three West African countries - Guinea, Liberia and Sierra Leone - means a number of promising treatments are bypassing the usual hurdles toward approval. Before a new drug gets the green light from U.S. regulators, researchers are required to conduct in-depth clinical trials on people to demonstrate the...

Read complete article

~	Sri Lanka: UN chief congratulates government on setting up office of missing persons

~	UN agency seeks $421M to support alternatives for refugees, migrants crossing to Europe

~	Libya: UN rights arm sounds alarm for safety of prisoners at imminent risk of torture

~	UN agency seeks $421 to support alternatives for refugees, migrants crossing to Europe

~	UNESCO chief calls for probe into killing of Honduran video journalist in Mexico

~	UN rights group concludes evaluation of Palestinians living under occupation

~	Civilians continue to bear the brunt of Afghanistan's 'ugly war' – UN report

~	Ahead of Sunday's consultation in Venezuela, UN voices concern for demonstrators

~	Faith central to hope and resilience, highlights UN chief, launching initiative to combat atrocities

~	Ahead of Sunday’s consultation in Venezuela, UN voices concern for demonstrators